Oxycodone Hydrochloride Patent Expiration
Oxycodone Hydrochloride was first introduced by Purdue Pharma Lp
Oxycodone Hydrochloride Patents
Given below is the list of patents protecting Oxycodone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Oxycontin | US8894987 | Tamper resistant dosage forms | Mar 29, 2030 | Purdue Pharma Lp |
| Roxybond | US10314788 | Pharmaceutical compositions configured to deter dosage form splitting | Aug 12, 2028 | Protega Pharms |
| Roxybond | US7955619 | Abuse resistant drugs, method of use and method of making | Aug 12, 2028 | Protega Pharms |
| Oxycontin | US11304908 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US11304909 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US11964056 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US12246094 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US12280152 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US8808741 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US8894988 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US9492389 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US9492391 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US9492392 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US9492393 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US9763933 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US9770416 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US9775808 | Tamper resistant dosage forms | Aug 24, 2027 | Purdue Pharma Lp |
| Oxycontin | US7776314 | Abuse-proofed dosage system |
Apr 19, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US10407434 | Process for preparing oxycodone compositions |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US10696684 | Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US12060361 | Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US7674799 | Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US7674800 | Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US7683072 | Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US9073933 | Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxycontin | US9522919 | Oxycodone compositions |
Mar 30, 2025
(Expired) | Purdue Pharma Lp |
| Oxaydo | US7201920 | Methods and compositions for deterring abuse of opioid containing dosage forms |
Mar 16, 2025
(Expired) | Zyla |
| Oxycontin | US8114383 | Abuse-proofed dosage form |
Oct 10, 2024
(Expired) | Purdue Pharma Lp |
| Oxaydo | US9492443 | Abuse deterrent compositions and methods of making same |
May 26, 2024
(Expired) | Zyla |
| Oxaydo | US7510726 | Methods and compositions for deterring abuse of opioid containing dosage forms |
Nov 26, 2023
(Expired) | Zyla |
| Oxaydo | US7981439 | Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof |
Nov 26, 2023
(Expired) | Zyla |
| Oxaydo | US8409616 | Extended release opioid abuse deterrent compositions and methods of making same |
Nov 26, 2023
(Expired) | Zyla |
| Oxaydo | US8637540 | Compositions for deterring abuse of opioid containing dosage forms |
Nov 26, 2023
(Expired) | Zyla |
| Oxycontin | US10130591 | Abuse-proofed dosage form |
Nov 20, 2023
(Expired) | Purdue Pharma Lp |
| Oxycontin | US10675278 | Crush resistant delayed-release dosage forms |
Nov 20, 2023
(Expired) | Purdue Pharma Lp |
| Oxycontin | US8309060 | Abuse-proofed dosage form |
Nov 20, 2023
(Expired) | Purdue Pharma Lp |
| Oxycontin | US10369109 | Abuse-proofed dosage form |
Jun 16, 2023
(Expired) | Purdue Pharma Lp |
| Oxycontin | US9675610 | Abuse-proofed dosage form |
Jun 16, 2023
(Expired) | Purdue Pharma Lp |
| Oxycontin | US8337888 | Pharmaceutical formulation containing gelling agent |
Aug 06, 2022
(Expired) | Purdue Pharma Lp |
| Oxycontin | US9060976 | Pharmaceutical formulation containing gelling agent |
Aug 06, 2022
(Expired) | Purdue Pharma Lp |
| Oxycontin | US6488963 | Hot-melt extrudable pharmaceutical formulation |
Jun 24, 2017
(Expired) | Purdue Pharma Lp |
| Oxycontin | US5508042 | Controlled release oxycodone compositions |
Apr 16, 2013
(Expired) | Purdue Pharma Lp |
Oxycodone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List